AbbVie Inc (BSP:ABBV34)
R$ 69.32 0 (0%) Market Cap: 1.97 Til Enterprise Value: 2.37 Til PE Ratio: 62.50 PB Ratio: 52.72 GF Score: 80/100

Abbvie Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 08, 2021 / 01:40PM GMT
Release Date Price: R$35.39 (-0.86%)
Terence C. Flynn
Goldman Sachs Group, Inc., Research Division - MD

Great. Good morning, everybody. I'm Terence Flynn, the U.S. biopharma analyst. Very pleased to welcome AbbVie. Joining us today from the company, we have Michael Severino, Vice Chairman and President; Rob Michael, Executive Vice President and CFO; and Jeff Stewart, Executive Vice President, Commercial Operations. Thanks so much, gentlemen, for joining us today. Really appreciate the time.

Michael E. Severino
AbbVie Inc. - Vice Chairman & President

It's a pleasure to be here.

Questions & Answers

Terence C. Flynn;Michael E. Severino
Goldman Sachs Group, Inc., Research Division - MD;

Well, maybe we'll jump right into it. Obviously, the COVID recovery is front and center for a number of folks. Maybe you could update us on the trends you're seeing across your various end markets, both in the U.S., Europe and Asia. And then how are you seeing those trends stack up in May versus what you saw back in April?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot